Barclays PLC Altamira Therapeutics Ltd. Transaction History

Barclays PLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 12, 2022	SELL	$0.48 - $1.66 $0 - $1	-1 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.69 - $1.92 $0 - $1	1 New	1 $0

Ticker CYTO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,009,710
Market Cap $172K
Description
Altamira Therapeutics Ltd. engages in developing therapeutics that address various unmet medical needs. Its commercial products include Bentrio, a drug-free nasal spray for personal protection against airborne viruses and allergens. The company is also involved in the development of RNA therapeutics for extrahepatic therapeutic targets, includin...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.